Revascularization in atherosclerotic renovascular disease: problems beyond the obstruction.
The main goal in the treatment of obstructive atherosclerotic renovascular disease (ARVD) is to preserve or recover renal function. The ARVD kidney continues to deteriorate in 20-40% of cases despite restoration of blood flow. Holden et al. report that renal function stabilized or improved in up to 97% of patients with the use of a distal embolic protection device.
Chade
A R
AR
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. chade.alejandro@mayo.edu
D000800:Angioplasty, Balloon / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D050197:Atherosclerosis / Q000150:complications* / Q000628:therapy*; D002404:Catheterization / Q000295:instrumentation / Q000379:methods; D018450:Disease Progression; D004617:Embolism / Q000517:prevention & control*; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000503:physiopathology; D012039:Regional Blood Flow / Q000502:physiology; D012078:Renal Artery Obstruction / Q000503:physiopathology / Q000628:therapy*; D015607:Stents